4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-285558
Chief Commercial Officer sold 2,867 shares at $45.03 ($129,101)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-25 | Sale : show line 1 in the form 10b5-1 | −2,867 | $45.03 | $129,101 | 174,633 | D |
| Open-market sales · 2,867 sh · avg $45.03 · $129,101 | ||||||
Loading xslF345X06/ownership.xml…